132 filings
Page 3 of 7
6-K
y71mdhw2w k3tt2m0
14 Jul 23
Current report (foreign)
12:17pm
6-K
04oz1 euuynws4dd3
12 Jul 23
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
9:23am
6-K
scklxfzyj9zjw
29 Jun 23
Current report (foreign)
4:01pm
6-K
vaa8ldeujjr
8 Jun 23
Current report (foreign)
4:30pm
6-K
8prpeld9t4xusznsv10
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
y5d26vd6hjlyei
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
paoudra5g
15 May 23
Condensed Financial Statements
4:51pm
6-K/A
nmn 31tbtnya83vwkgyg
4 May 23
Annual General Meeting of Shareholders to Be
8:19am
6-K
67vn7 t0f22m29h0v
3 May 23
Annual General Meeting of Shareholders to Be
5:25pm
6-K
iglx42sbbj60fcd45 a3
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am
6-K
pc62l4gkyld pg5es4j
28 Mar 23
PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery
9:16am
6-K
b8dxckn7okohq0kzpvaw
16 Mar 23
Current report (foreign)
8:09am
6-K
o96l2nm
14 Mar 23
PainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery
8:05am
6-K
kbzuvs
7 Feb 23
Current report (foreign)
4:11pm
6-K
q3p 47na5rbrjwmy
29 Dec 22
Current report (foreign)
4:31pm
6-K
4kzpv27sl d57
25 Nov 22
Annual General Meeting of Shareholders to Be
4:30pm
6-K
vsl 4lq2sk2nvw
15 Nov 22
PainReform Provides Business Update for the Third Quarter of 2022
8:47am
6-K
d6pao
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
x04zw73vpesl5nuzisub
8 Nov 22
PainReform Provides Further Update on Manufacturing of PRF-110
8:42am